Clinical Trial Update: Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy

View source ↗

Summary

This clinical trial update examines the clinical significance of circulating biomarkers in breast cancer patients treated with trastuzumab (Herceptin); the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Alberta Health services | Conditions: Breast Cancer | Status: UNKNOWN